Cipla Ltd. Announces Key Decisions in Board Meeting: Vice-Chairman Appointment, Director Resignation, and Investment in Subsidiary

Cipla Ltd. announced the outcome of its Board Meeting held on 19th March 2026. The meeting resulted in the appointment of Mr. P R Ramesh as Vice-Chairman, the resignation of Mr. Robert Stewart as an Independent Director, and an investment of up to USD 100 million in Cipla (EU) Limited, a wholly-owned subsidiary. The investment aims to provide financial assistance to InvaGen Pharmaceuticals Inc., another subsidiary, for various purposes. Additionally, the Board approved the Scheme of Amalgamation of Inzpera Healthsciences Limited, a wholly-owned subsidiary, with the company, subject to necessary approvals.